PrincyNirmalKumarMD

Infectious Disease • Washington, DC

Associate Professor of Medicine, Georgetown University

Join to view full profile

Dr. Kumar is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Kumar's full profile

Already have an account?

Office
3800 Reservoir Rd Nw
Washington, DC 20007
Phone+1 202-687-0845

Education & Training

MedStar Health/Georgetown University HospitalFellowship, Infectious Disease, 1988 - 1990
Hackensack University Medical Center/Englewood Hospital and Medical CenterResidency, Internal Medicine, 1985 - 1988
Kasturba Medical College ManipalClass of 1980

Certifications & Licensure

DC State Medical License 1988 - 2024
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2013-2014
Top Doctors:Washington DC Area Castle Connolly, 2012
Top Doctors:Washington-Baltimore Castle Connolly, 2012
Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Top MD Consumers Checkbook
Join now to see all

Clinical Trials

Antiviral Activity and Safety of Mifepristone at 2 Doses in HIV-1 Infected Subjects Start of enrollment: 2006 Jul 01
Completed
Phase 2
A Study in Underrepresented Patient Population or Regimen Tolerability: SUPPoRT Start of enrollment: 2008 Jul 01
Completed
Phase 3
FTC/RPV/TDF on T-Cell Activation, CD4+ T-Cell Count, Inflammatory Biomarkers and Viral Reservoir Start of enrollment: 2013 Apr 25
Completed
Phase 4
Ibalizumab Plus Optimized Background Regimen in Patient With Multi-Drug Resistant HIV Start of enrollment: 2015 Aug 01
Completed
Phase 3
Evaluating the Safety and Plasma Levels of N-Methanocarbathymidine (N-MCT) in Normal Patients Start of enrollment: 2016 Apr 01
Unknown status
Phase 1
COVID-19 Associated Lymphopenia Pathogenesis Study in Blood Start of enrollment: 2020 May 22
Recruiting
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

630 citations
Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease
Michael Charlton, Gregory T. Everson, Steven L. Flamm, Princy Kumar, Charles Landis
Gastroenterology. 2015-09-01
483 citations
Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Assoc...
Melanie A. Thompson, Michael J. Mugavero, K. Rivet Amico, Victoria A. Cargill, Larry W. Chang
Annals of Internal Medicine. 2012-06-05
130 citations
Role of Fas Ligand and Receptor in the Mechanism of T-Cell Depletion in Acquired Immunodeficiency Syndrome: Effect on CD4+ Lymphocyte Depletion and Human Immunodeficie...
Elaine M. Sloand, N. S. Young, P. Kumar, Frank F. Weichold, Tadatsugu Sato
Blood. 1997-02-15

Journal Articles

Phase 3 Study of Ibalizumab for Multidrug-Resistant HIV-1
Princy Kumar, MD, The New England Journal of Medicine

Press Mentions

Kumar Honored for Response, Mentorship During the PandemicApril 29th, 2022
MedStar Health Treats 1000th COVID-19 Patient with Monoclonal Antibody TherapyMarch 17th, 2021
The Cost-Effectiveness and Budget Impact of Ibalizumab-Uiyk for Adults with Multidrug-Resistant HIV-1 Infection in the United StatesFebruary 3rd, 2021
Join now to see all